Skip to main content
Premium Trial:

Request an Annual Quote

It's Been Published ... But Is It True?

In today's issue of Science, a news item looks into the recent challenge of a Cell paper by people who raised doubts about images published along with the transcription factor research.

A committee at the National Chung Hsing University in Taiwan, home of corresponding author Ban-Yang Chang, recommended that Chang retract the paper. Chang sent an e-mail to Science saying that the "conclusion we made for the Cell paper is true on the basis of our data."

While Chang continues to maintain the accuracy of his work, Science reports that more trouble is brewing: challenges have also cropped up regarding "another paper by Chang's team that was published online 16 October by the Journal of Biological Chemistry," according to Science writer Hao Xin.

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.